These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5169924)

  • 41. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for prevention of borderline leprosy reactions by dapsone.
    Barnetson RS; Pearson JM; Rees RJ
    Lancet; 1976 Nov; 2(7996):1171-2. PubMed ID: 62998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.
    Helmy HS; Pearson JM; Waters MF
    Lepr Rev; 1971 Sep; 42(3):167-77. PubMed ID: 4339652
    [No Abstract]   [Full Text] [Related]  

  • 46. Trial of high dosages of dapsone in the treatment of tuberculoid leprosy.
    Prasad BN
    Lepr Rev; 1971 Jun; 42(2):118-20. PubMed ID: 5150030
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
    [No Abstract]   [Full Text] [Related]  

  • 48. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
    Rostant MM
    Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of B.663 in human leprosy.
    Atkinson AJ; Sheagren JN; Rubio JB; Knight V
    Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
    [No Abstract]   [Full Text] [Related]  

  • 50. Summary of recent abstracts. 8. Leprosy.
    Browne SG
    Trop Dis Bull; 1971 Sep; 68(9):1021-30. PubMed ID: 4943397
    [No Abstract]   [Full Text] [Related]  

  • 51. Dapsone induced motor polyneuropathy.
    Jacob AJ; Rajendran A; Menezes J; Vaz M
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):341-3. PubMed ID: 1332194
    [No Abstract]   [Full Text] [Related]  

  • 52. DDS 100 mg daily, the cornerstone in the management of reversal reaction.
    van der Meulen J; Mock B
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):457-9. PubMed ID: 7200466
    [No Abstract]   [Full Text] [Related]  

  • 53. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 54. B.663 and erythema nodosum leprosum.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
    [No Abstract]   [Full Text] [Related]  

  • 55. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DDS 100 mg daily preventing permanent nerve damage in reversal reaction.
    Van der Meulen J
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):208-10. PubMed ID: 6249766
    [No Abstract]   [Full Text] [Related]  

  • 57. Reactive episodes in borderline lepromatous leprosy--a case report.
    Acharya PV; Gupta OP; Nigam SP; Agrawal RV
    Lepr India; 1976 Jul; 48(3):311-3. PubMed ID: 1022972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The management of leprosy and its complications.
    Trautman JR
    N Engl J Med; 1965 Sep; 273(14):756-8. PubMed ID: 5825688
    [No Abstract]   [Full Text] [Related]  

  • 59. DDS chemoprophylaxis for leprosy in children at Culion Sanitarium Palawan, Philippines.
    Lara CB
    Acta Leprol; 1978; (70):35-58. PubMed ID: 104537
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.